The goal of this learning activity is to provide doctors with a comprehensive review on the role of non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation (SPAF). Upon completing this module, participants will have a better understanding of the following aspects:

• Local and global burden of atrial fibrillation (AF)
• Modifiable AF risk factors and prevention strategies
• Current NOAC recommendations for SPAF
• The efficacy and safety profile of NOACs
• Real-world evidence of NOACs for SPAF

 
CPD Reviewer: Dr Aslannif Roslan
Consultant Cardiologist
Institute Jantung Negara;
Institute Jantung Negara Private
Kuala Lumpur, Malaysia

NOTE :

Please read thoroughly & understand the module before attempting the assessment questions.

Terms & Conditions: 

■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point. 
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points. 


The modules/articles are best viewed with:

Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards compliant browser
may be required to view the modules.